Immutable evidence record · ticker

Neurocrine Biosciences, Inc. (N1BI34)

Published as observed on 16 August 2026 at 01:59 BST.

Neurocrine Biosciences, Inc. has a not yet measurable company news read. Its latest completed weekly trend is positive.

As of
16 Aug 2026, 01:59
Scope
company and instrument
Evidence
4 items
Independent sources
0
Country
Brazil
Sector
Healthcare
Previous read
50.000
Change

Verification

Evidence links

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, Neurocrine Biosciences, Inc. (N1BI34), 2026-08-16, https://sharemaestro.com/evidence/cac2ec11-878c-4250-81db-4c460132bca1/
Record checksum d06bd3a5123a48de4ded0237877feffef32da77a55fe9b958bffce58d805345d

Evidence context